切换至 "中华医学电子期刊资源库"
高级检索
中华眼科医学杂志(电子版)

中华眼科医学杂志(电子版) ›› 2020, Vol. 10 ›› Issue (06) : 333 -338. doi: 10.3877/cma.j.issn.2095-2007.2020.06.003

论著

芪明颗粒对非增生期糖尿病视网膜病变患者视网膜微循环状态影响的临床研究
霍剑1, 段俊国2,†(), 朱柯宇3, 艾家玲3, 隋嘉庆3   
  1. 1. 611731　电子科技大学医学院附属妇女儿童医院·成都市妇女儿童中心医院眼科
    2. 610075　成都中医药大学眼科学院
    3. 610075　成都中医药大学眼科学院2018级硕士研究生
  • 收稿日期:2020-03-31 出版日期:2020-12-28
  • 通信作者: 段俊国
  • 基金资助:
    国家十二五科技支撑计划项目(2014BAI10B03)

Effect of Qiming granule on retinal vessel oxygen saturation in patients with non-proliferative diabetic retinopathy

Jian Huo1, Junguo Duan2,†(), Keyu Zhu3, Jialing Ai3, Jiaqing Sui3   

  1. 1. Department of Ophthalmology, Chengdu Women′s and Children′s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
    2. College of Ophthalmology, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
    3. Master′s degree 2018, College of Ophthalmology, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
  • Received:2020-03-31 Published:2020-12-28
  • Corresponding author: Junguo Duan
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

霍剑, 段俊国, 朱柯宇, 艾家玲, 隋嘉庆. 芪明颗粒对非增生期糖尿病视网膜病变患者视网膜微循环状态影响的临床研究[J]. 中华眼科医学杂志(电子版), 2020, 10(06): 333-338.

Jian Huo, Junguo Duan, Keyu Zhu, Jialing Ai, Jiaqing Sui. Effect of Qiming granule on retinal vessel oxygen saturation in patients with non-proliferative diabetic retinopathy[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2020, 10(06): 333-338.

目的

探讨芪明颗粒对非增生期糖尿病视网膜病变患者视网膜微循环状态的影响。

方法

纳入2016年10月至2017年5月于成都中医药大学附属医院眼科确诊为非增生期糖尿病视网膜病变(DR)的16例(31只眼)患者。其中，男性12例(23只眼)，女性4例(8只眼)；年龄49~75岁，平均年龄(62.5±8.3)岁。观察并记录芪明颗粒治疗前、治疗后4周、治疗后8周及治疗后12周患者的视力、眼底出血面积、糖化血红蛋白(HbA1c)、视网膜血氧饱和度、视网膜血管管径、眼平均灌注压的变化情况。治疗前后患者的视力、眼底出血面积、HbAlc、视网膜血氧饱和度、视网膜血管管径及眼平均灌注压等定量数据，以均数±标准差表示。采用单因素重复测量方差分析比较患者治疗前后视力的变化情况；采用配对样本t检验比较组内治疗前后HbAlc、视网膜血氧饱和度、视网膜血管管径及眼平均灌注压的变化。

结果

受试者糖尿病病程1~30年，平均(13.75±9.31)年。在治疗前、治疗后4周、治疗后8周及治疗后12周患者的视力分别为(73.81±7.90)、(73.97±8.53)、(74.74±7.29)及(76.26±6.80)。经单因素重复测量方差分析，治疗前后患者视力的比较，差异无统计学意义(F＝2.162，P>0.05)。治疗前患者的收缩压、舒张压、眼压及眼平均灌注压分别为(129.13±8.36)mmHg(1 mmHg＝0.133 kPa)、(74.44±6.92)mmHg、(15.58±2.90)mmHg及(46.06±4.90)mmHg。治疗后12周分别为(126.94±10.11)mmHg、(70.81±8.83)mmHg、(14.54±1.84)mmHg及(45.43±4.80)mmHg。经t检验，治疗前后患者收缩压、舒张压、眼压及眼平均灌注压的比较，差异无统计学意义(t＝0.797，1.383，1.853，0.538；P>0.05)。治疗前患者的HbAlc、视网膜静脉血氧饱和度平均值及视网膜动静脉血氧饱和度差值的平均值分别为(7.68±1.17)%、(63.18±7.07)%及(37.93±6.50)%。治疗后12周分别为(6.73±1.49)%、(60.16±5.21)%及(39.93±4.04)%。经t检验，治疗前后患者HbAlc、视网膜静脉血氧饱和度平均值及视网膜动静脉血氧饱和度差值平均值的比较，差异有统计学意义(t＝2.611，2.482，-2.259；P<0.05)。治疗前患者的眼底出血面积和视网膜动脉血氧饱和度平均值分别为(4713.70±8082.42)像素和(101.12±6.54)%。治疗后12周分别为(3776.66±6553.91)像素和(100.09±5.95)%。经t检验，治疗前后患者眼底出血面积和视网膜动脉血氧饱和度平均值的比较，差异无统计学意义(t＝1.571，1.047；P>0.05)。

结论

芪明颗粒可以降低非增生期糖尿病视网膜病变患者视网膜静脉血氧饱和度，增大视网膜动静脉血氧饱和度差值。

关键词: 糖尿病视网膜病变, 芪明颗粒, 视网膜血氧饱和度
Objective

The aim of this study was to explore the effect of Qiming granule on retinal microcirculation in patients with non-proliferative diabetic retinopathy (DR).

Methods

From October 2016 to May 2017, 16 eligible patients (31 eyes) with non-proliferative DR from the Department of Ophthalmology affiliated to Hospital of Chengdu University of Traditional Chinese Medicine were investigated. Among of them, including 12 male cases (23 eyes) and 4 female cases (8 eyes) with the average age (62.5±8.3) years-old. To observe and record the changes in visual acuity, fundus hemorrhage area, glycosylated hemoglobin (HbA1c), retinal blood oxygen saturation and vessel diameter, and the mean ocular perfusion pressure before and after treatment for 12 weeks with Qiming granule. The HbA1c, fundus hemorrhage area, retinal blood oxygen saturation and vessel diameter, and the mean ocular perfusion pressure before and after treatment were expressed by mean±standard deviation. The paired t testing was used to compare within groups. Visual acuity comparison adopts single factor repeated measures analysis of variance.

Results

The duration of diabetes in the subjects was 1 to 30 years, with an average of (13.75±9.31) years. Before and after treatment for 4, 8, 12 weeks, visual acuity were (73.81±7.90), (73.97±8.53), (74.74±7.29), and (76.26±6.80), respectively. After treatment for 12 weeks, visual acuity had a tendency to improve. After analysis of variance, the difference in visual acuity was not statistically significant before and after treatment (F=2.162, P>0.05). Before treatment, systolic blood pressure, diastolic blood pressure, the intraocular pressure, the mean ocular perfusion pressure were (129.13±8.36) mmHg (1 mmHg=0.133 kPa), (74.44±6.92) mmHg, (15.58±2.90) mmHg, (46.06±4.90) mmHg, respectively. After treatment for 12 weeks, those were (126.94±10.11) mmHg, (70.81±8.83) mmHg, (14.54±1.84) mmHg, (45.43±4.80) mmHg, respectively. After analysis of paired t testing, there were non-significant difference in systolic blood pressure, diastolic blood pressure, the intraocular pressure before and after the treatment (t=0.797, 1.383, 1.853, 0.538; P>0.05). Before treatment, HbAlc, the mean values of retinal vein blood oxygen saturation, the mean values of the difference in arterial and venous oxygen saturation were (7.68±1.17)%, (63.18±7.07)%, (37.93±6.50)%, respectively. After treatment for 12 weeks, those were (6.73±1.49)%, (60.16±5.21)%, (39.93±4.04)%, respectively. After analysis of paired t testing, there were significant difference in HbAlc, the mean values of retinal vein blood oxygen saturation, the mean values of the difference in arterial and venous oxygen saturation before and after the treatment (t=2.611, 2.482, -2.259; P<0.05). Before treatment, the fundus hemorrhage area and the mean values of retinal artery blood oxygen saturation (4713.70±8082.42) pixels, (101.12±6.54)%, respectively. After treatment for 12 weeks, those were (3776.66±6553.91) pixels, (100.09±5.95)%, respectively. After analysis of paired t testing, there were non-significant difference in the fundus hemorrhage area and the mean values of retinal artery blood oxygen saturation before and after the treatment (t= 1.571, 1.047; P>0.05).

Conclusions

Qiming granule could reduce retinal venous oxygen saturation and increase the mean values of the difference in arterial and venous oxygen saturation in patients with non-proliferative DR.

Key words: Diabetic retinopathy, Qiming granule, Retinal oxygen saturation
表1 治疗前后患者视网膜血氧饱和度的比较(±s，%)
项目 动脉血氧饱和度 静脉血氧饱和度
颞上 鼻上 鼻下 颞下 平均值 颞上 鼻上 鼻下
眼数(只) 25 29 29 23 31 27 28 30
治疗前 99.44±6.27 102.58±6.85 101.59±8.34 98.50±8.99 101.12±6.54 63.77±7.90 67.28±8.59 66.52±8.07
治疗后12周 98.75±8.08 100.96±8.44 100.67±8.58 98.47±8.33 100.09±5.95 61.74±7.61 64.38±7.69 61.50±7.20
t值 0.423 1.350 0.617 0.021 1.047 1.261 1.514 3.335
P值 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 <0.05
项目 静脉血氧饱和度 动静脉血氧饱和度差值
颞下 平均值 颞上 鼻上 鼻下 颞下 平均值
眼数(只) 25 31 23 27 28 21 31
治疗前 62.22±11.11 63.18±7.07 35.78±7.87 35.24±7.04 34.68±9.87 37.80±11.89 37.93±6.50
治疗后12周 60.48± 6.59 60.16±5.21 37.21±9.64 36.80±8.07 38.93±9.49 37.91± 8.67 39.93±4.04
t值 1.025 2.482 -0.907 -0.870 -2.182 0.127 -2.259
P值 >0.05 <0.05 >0.05 >0.05 <0.05 >0.05 <0.05
表2 患者治疗前后视网膜血管管径的比较(±s，μm)
项目 动脉管径 静脉管径
颞上 鼻上 鼻下 颞下 平均值 颞上 鼻上 鼻下
眼数(只) 25 29 29 23 31 27 28 30
治疗前 131.08±21.50 118.52±21.68 106.03±21.37 128.22±22.69 119.70±14.39 172.07±34.81 142.29±29.31 146.97±39.43
治疗后12周 120.24±20.21 115.59±17.72 107.38±19.25 129.48±19.96 117.30±11.66 158.37±39.57 150.03±29.24 150.23±38.39
t值 2.776 0.888 -0.360 -0.330 1.269 1.524 -1.076 -0.576
P值 <0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
项目 静脉管径 动静脉管径比值
颞下 平均值 颞上 鼻上 鼻下 颞下 平均值
眼数(只) 25 31 23 27 28 21 31
治疗前 170.28±40.26 157.78±20.09 0.77±0.15 0.87±0.28 0.77±0.23 0.76±0.18 0.77±0.10
治疗后12周 165.16±32.82 155.06±20.02 0.81±0.22 0.79±0.19 0.75±0.22 0.79±0.20 0.77±0.13
t值 0.729 0.594 -0.501 1.532 0.435 -1.276 -0.098
P值 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
[1]
Chistiakov DA. Diabetic retinopathy: Pathogenic mechanisms and current treatments[J]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2011, 5(3): 165-172.
[2]
Hardarson SH, Stefánsson E. Retinal oxygen saturation is altered in diabetic retinopathy[J]. Br J Ophthalmol, 2012, 96(4): 560-563.
[3]
Hammer M, Vilser W, Riemer T, et al. Diabetic patients with retinopathy show increased retinal venous oxygen saturation[J]. Graefes Arch Clin Exp Ophthalmol, 2009, 247(8): 1025-1030.
[4]
Kifley A, Wang JJ, Cugati S, et al. Retinal vascular caliber, diabetes, and retinopathy[J]. Am J Ophthalmol, 2007, 143(6): 1024-1026.
[5]
Dong YM, Lin LL, Yan H, et al. Shifts in retinal vessel diameter and oxygensaturation in Chinese type 2 diabetes mellitus patients[J]. BMC Ophthalmology, 2016, 16: 43.
[6]
Luo XX, Duan JG, Liao PZ, et al. Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial[J]. Chin J of Integr Med, 2009, 15(5): 384-388.
[7]
李科军，赵智华，樊芳，等. 芪明颗粒对糖尿病患者脉络膜循环的影响[J]. 国际眼科杂志，2016，16(3)：499-501.
[8]
中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志，2014，50(11)：851-865.
[9]
Pournaras CJ, Rungger-Brandle E, Riva CE, et al. Regulation of retinal blood flow in health and disease[J]. Prog Retin Eye Res, 2008, 27(3): 284-330.
[10]
张栩. 基于代谢组学的2型糖尿病及其微血管并发症的中医证候生物学评价研究[D]. 成都：成都中医药大学，2017.
[11]
Bourne RRA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990—2010: a systematic analysis[J]. The Lancet Global Health, 2013, 1(6): e339-e349.
[12]
Xu Y, Wang L, He J. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310: 948-959.
[13]
Yau J, Rogers S, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564.
[14]
段俊国，廖品正，吴烈，等. 中药复方芪明颗粒治疗糖尿病视网膜病变双盲双模拟随机对照多中心临床研究[J]. 成都中医药大学学报，2006，29(2)：1-5.
[15]
李洪超，许扬扬. 芪明颗粒治疗糖尿病视网膜病变的疗效及经济性评价[J]. 药品评价，2014，11(2)：33-39.
[16]
章林慧，吴永江，谢秀琼. 正交实验法优选芪明颗粒提取工艺的研究[J]. 时珍国医国药，2008，19(9)：2168-2169.
[17]
黄菁，王丽波，刘俐利. 羟苯磺酸钙联合芪明颗粒治疗对非增殖期糖尿病视网膜病变患者脉络膜以及血清支链氨基酸、细胞因子的影响[J]. 海南医学院学报，2016，22(18)：2202-2204.
[18]
冯海江，周和定，宋文慧. 芪明颗粒联合血栓通胶囊治疗糖尿病视网膜病变的临床研究[J]. 中国中医药科技，2015，22(3)：255-256.
[19]
董如娇，陈芳，赵霞，等. 全视网膜光凝联合药物治疗糖尿病视网膜病变的临床观察[J]. 中国中医眼科杂志，2015，25(2)：114-117.
[20]
宋剑涛. 芪明颗粒治疗糖尿病视网膜病变随机、阳性药对照、多中心临床研究[D]. 成都：成都中医药大学，2004.
[21]
吴建国. 芪明颗粒治疗中、重度非增生性糖尿病视网膜病变的临床研究[D]. 北京：中国中医科学院，2011.
[22]
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志，2018，10(1)：4-67.
[23]
蹇文渊. 芪明颗粒治疗糖尿病视网膜病变的单病例随机对照试验研究[D]. 成都：成都中医药大学，2013.
[24]
陈新. 芪明颗粒对糖尿病微血管病变眼肾损害的影响[D]. 成都：成都中医药大学，2013.
[25]
曾果，刘刚，刘晖，等. 芪明颗粒对单纯型糖尿病视网膜病变患者视网膜功能的影响[J]. 国际眼科杂志，2015，15(3): 495-498.
[26]
Behl T, Kotwani A. Chinese herbal drugs for the treatment of diabetic retinopathy[J]. J Pharm Pharmacol, 2017, 69(3): 223-235.
[27]
Christine A, Schmidt MHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration[J]. Int J Mol Sci, 2018, 19(1): 110.
[28]
曹平. 糖尿病微血管并发症视网膜血管管径的变化及芪明颗粒干预的影响[D]. 成都：成都中医药大学，2016.
[29]
刘路宏，廖品正，段俊国，等. 芪明对实验性糖尿病大鼠视网膜胰岛素样生长因子-1的影响[C]. 南宁：第七次全国中医糖尿病学术大会，2003：4.
[30]
Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy[J]. Surv Ophthalmol, 2006, 51: 364-380.
[31]
Bahram K, Kim F, Hilary T. Retinal arterial and venous oxygen saturation is altered in diabetic patients[J]. Invest Ophthalmol Vis Sci, 2013, 54: 7103-7106.
[32]
Jorgensen CM, Hardarson SH, Bek T. The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision threatening retinopathy[J]. Acta Ophthalmol, 2014, 92(1): 34-39.
[33]
Man RE, Sasongko MB, Kawasaki R, et al. Associations of retinal oximetry in healthy young adults[J]. Invest Ophthalmol Vis Sci, 2014, 55(3): 1763-1769.
[34]
蹇文渊. 视网膜血管血氧饱和度及管径在病证结合辨证分析中的应用研究[D]. 成都：成都中医药大学，2016.
[35]
Khoobehi B, Firn K, Thompson H, et al. Retinal arterial and venous oxygen saturation is altered in diabetic patients.[J]. Invest Ophthalmol Vis Sci, 2013, 54(10): 7103-7106.
[36]
Nguyen TT, Wang JJ, Islam FM, et al. Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study[J]. Diabetes, 2008, 57(3): 536-539.
[37]
Steel DH, Habib MS, Al-Diri B, et al. The association between retinal vascular geometry changes and diabetic retinopathy and their role in prediction of progression: an exploratory study[J]. BMC Ophthalmol, 2014, 14: 89.
[1] 王珏, 陈赛君, 贲志飞, 詹锦勇, 徐开颖. 剪切波弹性成像联合极速脉搏波技术评估颈动脉弹性对糖尿病性视网膜病变的预测价值[J]. 中华医学超声杂志（电子版）, 2023, 20(06): 636-641.
[2] 罗红, 袁昌亮, 陈岚. MiR-3202对高糖诱导的人视网膜血管内皮细胞损伤的影响[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(03): 155-160.
[3] 程莉, 章晓良. 血尿酸和胱抑素C与糖尿病视网膜病变患者合并糖尿病肾病的关系及影响因素[J]. 中华肾病研究电子杂志, 2023, 12(04): 194-199.
[4] 李京珂, 张妍春, 武佳懿, 任秀瑜. 深度学习在糖尿病视网膜病变筛查、评级及管理中的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 241-246.
[5] 张新媛, 王麒雲, 陈晓思. 糖尿病视网膜病变血管内皮细胞与神经细胞藕联二维体外共培养模型的实验研究[J]. 中华眼科医学杂志(电子版), 2023, 13(01): 6-11.
[6] 李茹月, 李明华, 张凯文, 张悦, 牟大鹏, 王宁利, 刘含若. 早期筛查老年人群糖尿病视网膜病变的卫生经济学分析[J]. 中华眼科医学杂志(电子版), 2022, 12(04): 216-221.
[7] 李茹月, 刘含若. 卫生经济学评价常见致盲眼病筛查的进展[J]. 中华眼科医学杂志(电子版), 2021, 11(02): 94-98.
[8] 丁云鹤, 严棽棽, 王璐, 陈燕云, 宋婷婷, 张璐, 李哲清, 杨智, 田蓓. 增殖性糖尿病视网膜病变虹膜新生血管的多模态临床研究[J]. 中华眼科医学杂志(电子版), 2021, 11(01): 8-13.
[9] 方立建, 魏文斌. 康柏西普玻璃体腔内注射联合阈值下微脉冲激光治疗糖尿病黄斑水肿的临床研究[J]. 中华眼科医学杂志(电子版), 2020, 10(02): 90-96.
[10] 于海生, 刘鹤南, 陈晓隆, 吴娜. 糖尿病视网膜病变患者血清微核糖核酸表达谱的初步研究[J]. 中华眼科医学杂志(电子版), 2019, 09(04): 246-251.
[11] 李昕格, 丁旭晨, 刘国丹. 光学相干断层扫描血管成像在糖尿病患者早期黄斑区视网膜微循环评估中的应用[J]. 中华眼科医学杂志(电子版), 2019, 09(03): 187-192.
[12] 冉启玉, 汤怀鹏, 孔蕾, 孙冰. 糖尿病视网膜病变中神经退行性变的发病机制及其潜在的治疗方法[J]. 中华诊断学电子杂志, 2023, 11(02): 120-124.
[13] 冉启玉, 杜鹏宇, 孔蕾, 孙冰. 神经酰胺与糖尿病及其并发症关系研究进展[J]. 中华诊断学电子杂志, 2022, 10(03): 158-162.
[14] 杨莲, 罗争, 龚娇. 合并阻塞性睡眠呼吸暂停低通气综合征对老年人2型糖尿病视网膜病变的影响[J]. 中华老年病研究电子杂志, 2022, 09(03): 33-36.
[15] 李伟, 王青. 延续性护理干预对老年2型糖尿病视网膜病变患者血糖和视力水平的控制效果[J]. 中华老年病研究电子杂志, 2021, 08(03): 48-51.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号